First Header Logo Second Header Logo

Connection

Thomas Shupe to Hepatocytes

This is a "connection" page, showing publications Thomas Shupe has written about Hepatocytes.
Connection Strength

0.850
  1. Deegan DB, Zimmerman C, Skardal A, Atala A, Shupe TD. Stiffness of hyaluronic acid gels containing liver extracellular matrix supports human hepatocyte function and alters cell morphology. J Mech Behav Biomed Mater. 2015 Mar; 55:87-103.
    View in: PubMed
    Score: 0.496
  2. Shupe T, Petersen BE. Potential applications for cell regulatory factors in liver progenitor cell therapy. Int J Biochem Cell Biol. 2011 Feb; 43(2):214-21.
    View in: PubMed
    Score: 0.087
  3. Petersen B, Shupe T. Location is everything: the liver stem cell niche. Hepatology. 2008 Jun; 47(6):1810-2.
    View in: PubMed
    Score: 0.074
  4. Ellor S, Shupe T, Petersen B. Stem cell therapy for inherited metabolic disorders of the liver. Exp Hematol. 2008 Jun; 36(6):716-725.
    View in: PubMed
    Score: 0.073
  5. Jung Y, Oh SH, Zheng D, Shupe TD, Witek RP, Petersen BE. A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells. Lab Invest. 2006 May; 86(5):477-89.
    View in: PubMed
    Score: 0.064
  6. Shupe T, Sell S. Low hepatic glutathione S-transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized mice. Toxicol Lett. 2004 Mar 14; 148(1-2):1-9.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.